- Home
- SDSTW vs QNRX Comparison
SDSTW vs QNRX Comparison
Compare SDSTW & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDSTW
- QNRX
- Stock Information
- Founded
- SDSTW N/A
- QNRX 2018
- Country
- SDSTW United States
- QNRX United States
- Employees
- SDSTW 8
- QNRX N/A
- Industry
- SDSTW
- QNRX Medical/Dental Instruments
- Sector
- SDSTW
- QNRX Health Care
- Exchange
- SDSTW Nasdaq
- QNRX Nasdaq
- Market Cap
- SDSTW 3.0M
- QNRX 3.3M
- IPO Year
- SDSTW N/A
- QNRX N/A
- Fundamental
- Price
- SDSTW $0.03
- QNRX $8.86
- Analyst Decision
- SDSTW
- QNRX
- Analyst Count
- SDSTW 0
- QNRX 0
- Target Price
- SDSTW N/A
- QNRX N/A
- AVG Volume (30 Days)
- SDSTW 41.6K
- QNRX 16.5K
- Earning Date
- SDSTW 03-26-2025
- QNRX 08-07-2025
- Dividend Yield
- SDSTW N/A
- QNRX N/A
- EPS Growth
- SDSTW N/A
- QNRX N/A
- EPS
- SDSTW N/A
- QNRX N/A
- Revenue
- SDSTW N/A
- QNRX N/A
- Revenue This Year
- SDSTW N/A
- QNRX N/A
- Revenue Next Year
- SDSTW N/A
- QNRX N/A
- P/E Ratio
- SDSTW N/A
- QNRX N/A
- Revenue Growth
- SDSTW N/A
- QNRX N/A
- 52 Week Low
- SDSTW $0.10
- QNRX $5.01
- 52 Week High
- SDSTW $0.12
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- SDSTW N/A
- QNRX 55.36
- Support Level
- SDSTW N/A
- QNRX $8.04
- Resistance Level
- SDSTW N/A
- QNRX $9.19
- Average True Range (ATR)
- SDSTW 0.00
- QNRX 0.43
- MACD
- SDSTW 0.00
- QNRX -0.03
- Stochastic Oscillator
- SDSTW 0.00
- QNRX 61.40
About SDSTW Stardust Power Inc. Warrant
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.